Device
CURATE.AI
CURATE.AI is a medical device with 6 clinical trials. Currently 1 active trials ongoing.
Total Trials
6
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
1(17%)
Phase Distribution
Ph not_applicable
2
33%
Ph phase_1
3
50%
Phase Distribution
3
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
3(60.0%)
N/ANon-phased studies
2(40.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
6
all time
Status Distribution
Active(1)
Other(5)
Detailed Status
unknown5
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
1
Success Rate
N/A
Most Advanced
Phase 1
Trials by Phase
Phase 13 (60.0%)
N/A2 (40.0%)
Trials by Status
recruiting117%
unknown583%
Recent Activity
1 active trials
Showing 5 of 6
recruitingphase_1
Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI
NCT05381038
unknownnot_applicable
AI for Anti-hypertensive Medication Titration
NCT05376683
unknownphase_1
PRECISE CURATE.AI Pilot Clinical Trial
NCT04522284
unknownphase_1
Nivolumab and Pembrolizumab Dose Optimisation in Solid Tumours With CURATE.AI Platform and Sequential ctDNA Measurements
NCT05175235
unknownnot_applicable
CURATE.AI COR-Tx Trial for Post Brain Radiotherapy Patients
NCT04848935
Clinical Trials (6)
Showing 6 of 6 trials
NCT05381038Phase 1
Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI
NCT05376683Not Applicable
AI for Anti-hypertensive Medication Titration
NCT04522284Phase 1
PRECISE CURATE.AI Pilot Clinical Trial
NCT05175235Phase 1
Nivolumab and Pembrolizumab Dose Optimisation in Solid Tumours With CURATE.AI Platform and Sequential ctDNA Measurements
NCT04848935Not Applicable
CURATE.AI COR-Tx Trial for Post Brain Radiotherapy Patients
NCT04769141
Artificial Intelligence Guided Personalised Medicine in Patients With Hypertension and Diabetes
All 6 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 6